Showing results (1-10 of 254) with videos related to
Sort By:
Pageof 26
Transplant International : Official Journal of the European Society for Organ Transplantation|March 19, 2008
Bone disease after kidney transplantationChrista Mitterbauer, Rainer OberbauerHealth and Quality of Life Outcomes|January 10, 2004
Health-related quality of life outcomes after kidney transplantationWolfgang Fiebiger, Christa Mitterbauer, Rainer OberbauerBone|October 31, 2006
Age and sex are sufficient for predicting fractures occurring within 1 year of hemodialysis treatmentChrista Mitterbauer, Reinhard Kramar, Rainer OberbauerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2006
Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trialsChrista Mitterbauer, Christoph Schwarz, Martin Haas, et al.Kidney International|December 17, 2003
Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantationChristoph Schwarz, Christa Mitterbauer, Georg Heinze, et al.Journal of the American Society of Nephrology : JASN|July 25, 2008
Statin use is associated with prolonged survival of renal transplant recipientsFranz Wiesbauer, Georg Heinze, Christa Mitterbauer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2008
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrationsChrista Mitterbauer, Georg Heinze, Alexander Kainz, et al.Transplantation|June 23, 2009
Calcineurin inhibitor-based immunosuppressive therapy, donor age, and long-term outcome after kidney transplantationGeorg Heinze, Rainer Oberbauer, Alexander Kainz, et al.Transplantation|September 16, 2003
Impaired tubulointerstitial expression of endothelin-1 and nitric oxide isoforms in donor kidney biopsies with postischemic acute renal failureChrista Mitterbauer, Christoph Schwarz, Peter Hauser, et al.Journal of the American Society of Nephrology : JASN|February 17, 2006
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantationGeorg Heinze, Christa Mitterbauer, Heinz Regele, et al.Pageof 26